Nuveen Covered Call Closed-End Funds Announce Completion of Mergers
Key Terms
closed-end funds financial
net asset values financial
Through the mergers, a wholly-owned subsidiary of SPXX acquired substantially all of the assets and liabilities of BXMX and DIAX in tax-free transactions, and common shares of each of BXMX and DIAX were converted to newly-issued common shares of SPXX in an aggregate amount equal to the value of each Fund’s net assets. The transactions took place based upon the closing net asset values of the Funds on March 27, 2026. The exchange ratios at which common shares of BXMX and DIAX were converted to common shares of SPXX are listed below:
Ticker |
Fund Name |
Exchange Ratio |
BXMX |
Nuveen S&P 500 Buy-Write Income Fund |
0.83966629 |
DIAX |
Nuveen Dow 30℠ Dynamic Overwrite Fund |
0.89021446 |
Nuveen is a leading sponsor of closed-end funds (CEFs) with
About Nuveen
Nuveen is a global investment leader, managing
The information contained on the Nuveen website is not a part of this press release.
Important information on risk
Past performance is no guarantee of future results. All investments carry a certain degree of risk, including the possible loss of principal, and there is no assurance that an investment will provide positive performance over any period of time. Certain products and services may not be available to all entities or persons. There is no guarantee that investment objectives will be achieved.
Closed-end funds frequently trade at a discount from net asset value (NAV). At any point in time, including when sold, shares may be worth more or less than the purchase price or the net asset value, even after considering the reinvestment of fund distributions. It is important to consider the objectives, risks, charges and expenses of any fund before investing.
5343701
View source version on businesswire.com: https://www.businesswire.com/news/home/20260330723414/en/
For more information, please visit Nuveen’s CEF homepage www.nuveen.com/closed-end-funds or contact:
Financial Professionals:
800-752-8700
Investors:
800-257-8787
Media:
media-inquiries@nuveen.com
Source: Nuveen